Nanomedicine: A primer for surgeons

Pediatric Surgery International

Volumn 28, Issue 10, 2012, Pages 943-951

  Wong, K K Y ^a   Liu, X L ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Nanodiagnostics; Nanomedicine; Nanoparticles; Therapeutics

Indexed keywords

DNA VACCINE; IRON OXIDE; NANOCARRIER; NANOPARTICLE; PLASMID DNA; SILVER NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE;

DIAGNOSTIC TEST; DRUG DELIVERY SYSTEM; FLUORESCENCE IMAGING; GENE TARGETING; HUMAN; IN VIVO STUDY; NANOMEDICINE; NANOPROBE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; SURGEON;

CLINICAL COMPETENCE; GENERAL SURGERY; HUMANS; NANOMEDICINE; NANOTECHNOLOGY; PHYSICIANS;

EID: 84866740061     PISSN: 01790358     EISSN: 14379813     Source Type: Journal    
DOI: 10.1007/s00383-012-3162-y     Document Type: Review

References (106)

1. Wong KKY, Liu XL (2010) Silver nanoparticles-the real "silver bullet" in clinical medicine? Med Chem Commun 1:125-131
2. Bhattacharya R, Mukherjee P (2008) Biological properties of "naked" metal nanoparticles. Adv Drug Deliv Rev 60:1289-1306
3. Hirst SM, Karakoti AS, Tyler RD et al (2009) Anti-inflammatory properties of cerium oxide nanoparticles. Small 5:2848-2856
4. Bae KH, Chung HJ, Park TG (2011) Nanomaterials for cancer therapy and imaging. Mol Cells 31:295-302
5. Barreto JA, O'Malley W, Kubeil M et al (2011) Nanomaterials: applications in cancer imaging and therapy. Adv Mater 23:H18-H40
6. Jain KK (2008) Recent advances in nanooncology. Technol Cancer Res Treat 7:1-13
7. Jain KK (2010) Advances in the field of nanooncology. BMC Med 8:83
8. Ranganathan R, Madanmohan S, Kesavan A et al (2012) Nanomedicine: towards development of patient-friendly drugdelivery systems for oncological applications. Int J Nanomedicine 7:1043-1060
9. Modi G, Pillay V, Choonara YE et al (2009) Nanotechnological applications for the treatment of neurodegenerative disorders. Prog Neurobiol 88:272-285
10. Modi G, Pillay V, Choonara YE (2010) Advances in the treatment of neurodegenerative disorders employing nanotechnology. Ann N Y Acad Sci 1184:154-172
11. Brambilla D, Le Droumaguet B, Nicolas J et al (2011) Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues. Nanomedicine 7:521-540
12. Bottini M, Rosato N, Bottini N (2011) PEG-modified carbon nanotubes in biomedicine: current status and challenges ahead. Biomacromolecules 12:3381-3393
13. Rahman AM, Yusuf SW, Ewer MS (2007) Anthracyclineinduced cardiotoxicity and the cardiac-sparing effect of liposomal formulation. Int J Nanomedicine 2:567-583
14. Iverson N, Plourde N, Chnari E et al (2008) Convergence of nanotechnology and cardiovascular medicine: progress and emerging prospects. BioDrugs 22:1-10
15. Cyrus T, Wickline SA, Lanza GM (2012) Nanotechnology in interventional cardiology. Wiley Interdiscip Rev Nanomed Nanobiotechnol 4:82-95
16. Balasundaram G, Webster TJ (2007) An overview of nano-polymers for orthopedic applications. Macromol Biosci 7:635-642
17. Streicher RM, Schmidt M, Fiorito S (2007) Nanosurfaces and nanostructures for artificial orthopedic implants. Nanomedicine (Lond) 2:861-874
18. Chun YW, Webster TJ (2009) The role of nanomedicine in growing tissues. Ann Biomed Eng 37:2034-2047
19. Laurencin CT, Kumbar SG, Nukavarapu SP (2009) Nanotechnology and orthopedics: a personal perspective. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1:6-10
20. Jain KK (2008) Nanomedicine: application of nanobiotechnology in medical practice. Med Princ Pract 17:89-101
21. Nasir AR, Brenner SA (2012) Think small: nanotechnology for plastic surgeons. Ann Plast Surg (epub ahead of print)
22. Chong EJ, Phan TT, Lim IJ et al (2007) Evaluation of electrospun PCL/gelatin nanofibrous scaffold for wound healing and layered dermal reconstitution. Acta Biomater 3:321-330
23. Gimi B, Leong T, Gu Z et al (2005) Self-assembled 3D radiofrequency- shielded (RS) containers for cell encapsulation. Biomed Microdevices 7:341-345
24. John R, Rezaeipoor R, Adie SG et al (2010) In vivo magnetomotive optical molecular imaging using targeted magnetic nanoprobes. Proc Natl Acad Sci USA 107:8085-8090
25. John R, Boppart SA (2011) Magnetomotive molecular nanoprobes. Curr Med Chem 18:2103-2114
26. Solomon M, D'Souza GG (2011) Recent progress in the therapeutic applications of nanotechnology. Curr Opin Pediatr 23:215-220
27. Lee Y, Lee H, Kim YB et al (2008) Bioinspired surface immobilization of hyaluronic acid on monodisperse magnetite nanocrystals for targeted cancer imaging. Adv Mater 20:1-4
28. Bae KH, Lee K, Kim C et al (2011) Surface functionalized hollow manganese oxide nanoparticles for cancer targeted siRNA delivery and magnetic resonance imaging. Biomaterials 32:176-184
29. Lee JH, Lee K, Moon SH et al (2009) All-in-one target-cellspecific magnetic nanoparticles for simultaneous molecular imaging and siRNA delivery. Angew Chem Int Ed Engl 48: 4174-4179
30. Shinoda J, Yano H, Yoshimura S et al (2003) Fluorescenceguided resection of glioblastoma multiforme by using high-dose fluorescein sodium. Technical note. J Neurosurg 99:597-603
31. Britz GW, Ghatan S, Spence AM et al (2002) Intracarotid RMP- 7 enhanced indocyanine green staining of tumors in a rat glioma model. J Neurooncol 56:227-232
32. Ozawa T, Britz GW, Kinder DH et al (2005) Bromophenol blue staining of tumors in a rat glioma model. Neurosurgery 57: 1041-1047
33. Orringer DA, Chen T, Huang DL et al (2010) The brain tumor window model: a combined cranial window and implanted glioma model for evaluating intraoperative contrast agents. Neurosurgery 66:736-743
34. Koo YE, Reddy GR, Bhojani M et al (2006) Brain cancer diagnosis and therapy with nanoplatforms. Adv Drug Deliv Rev 58:1556-1577
35. Reddy GR, Bhojani MS, McConville P et al (2006) Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin Cancer Res 12:6677-6686
36. Veiseh O, Gunn JW, Kievit FM et al (2009) Inhibition of tumorcell invasion with chlorotoxin-bound superparamagnetic nanoparticles. Small 5:256-264
37. Veiseh O, Sun C, Fang C et al (2009) Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier. Cancer Res 69:6200-6207
38. Sun C, Du K, Fang C et al (2010) PEG-mediated synthesis of highly dispersive multifunctional superparamagnetic nanoparticles: their physicochemical properties and function in vivo. ACS Nano 4:2402-2410
39. Orringer DA, Koo YE, Chen T et al (2009) In vitro characterization of a targeted, dye-loaded nanodevice for intraoperative tumor delineation. Neurosurgery 64:965-971
40. Nie G, Hah HJ, Kim G et al (2012) Hydrogel nanoparticles with covalently linked coomassie blue for brain tumor delineation visible to the surgeon. Small 8:884-891
41. Jain KK (2007) Applications of nanobiotechnology in clinical diagnostics. Clin Chem 53:2002-2009
42. Lee WG, Kim YG, Chung BG et al (2010) Nano/microfluidics for diagnosis of infectious diseases in developing countries. Adv Drug Deliv Rev 62:449-457
43. Tanury P, Malhotra A, Byrne LM et al (2010) Nanobioimaging and sensing of infectious diseases. Adv Drug Deliv Rev 62:424-437
44. Jamieson T, Bakhshi R, Petrova D et al (2007) Biological applications of quantum dots. Biomaterials 28:4717-4732
45. Smith AM, Duan HW, Mohs AM et al (2008) Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv Drug Deliv Rev 60:1226-1240
46. Gao JH, Chen XY, Cheng Z (2010) Near-infrared quantum dots as optical probes for tumor imaging. Curr Top Med Chem 10:1147-1157
47. He XX, Gao JH, Gambhir SS et al (2010) Near-infrared fluorescent nanoprobes for cancer molecular imaging: status and challenges. Trends Mol Med 12:574-583
48. Hu M, Yan J, He Y et al (2010) Ultrasensitive, multiplexed detection of cancer biomarkers directly in serum by using a quantum dotbased microfluidic protein chip. ACS Nano 4:488-494
49. Chi XQ, Huang DT, Zhao ZH et al (2012) Nanoprobes for in vitro diagnostics of cancer and infectious diseases. Biomaterials 33:189-206
50. Gill R, Zayats M, Willner I (2008) Semiconductor quantum dots for bioanalysis. Angew Chem Int Edit 47:7602-7625
51. Frasco MF, Chaniotakis N (2009) Semiconductor quantum dots in chemical sensors and biosensors. Sensors 9:7266-7286
52. Dillon RL, Muller WJ (2010) Distinct biological roles for the akt family in mammary tumor progression. Cancer Res 70:4260-4264
53. Stoffel A (2010) Targeted therapies for solid tumors: current status and future perspectives. BioDrugs 24:303-316
54. Gialeli C, Theocharis AD, Karamanos NK (2011) Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 278(1):16-27
55. Pastorino F, Marimpietri D, Brignole C et al (2007) Ligandtargeted liposomal therapies of neuroblastoma. Curr Med Chem 14:3070-3078
56. Rajput MS, Agrawal P (2010) Microspheres in cancer therapy. Indian J Cancer 47:458-468
57. Campbell RB (2006) Tumor physiology and delivery of nanopharmaceuticals. Anticancer Agents Med Chem 6:503-512
58. Rzigalinski BA, Strobl JS (2009) Cadmium-containing nanoparticles: perspectives on pharmacology and toxicology of quantum dots. Toxicol Appl Pharmacol 238:280-288
59. Yuan F, Dellian M, Fukumura D et al (1995) Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 55:3752-3756
60. Meng H, Xue M, Xia T et al (2011) Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model. ACS Nano 5:4131-4144
61. Keereweer S, Mol IM, Kerrebijn JD et al (2010). Targeting integrins and enhanced permeability and retention (EPR) effect for optical imaging of oral cancer. J Surg Oncol (epub ahead of print)
62. Fang J, Qin H, Nakamura H et al (2012) Carbon monoxide, generated by heme oxygenase-1, mediates the enhanced permeability and retention effect in solid tumors. Cancer Sci 103: 535-541
63. Bae KH, Chung HJ et al (2011) Nanomaterials for cancer therapy and imaging. Mol Cells 31:295-302
64. Kataoka K, Harada A, Nagasaki Y (2001) Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev 47:113-131
65. Mok H, Bae KH, Ahn CH et al (2019) PEGylated and MMP-2 specifically dePEGylated quantum dots: comparative evaluation of cellular uptake. Langmuir 25:1645-1650
66. Lee PY, Zhu YF, Yan JJ et al (2010) The cytotoxic effects of lipidic formulated gold porphyrin nanoparticles for the treatment of neuroblastoma. Nanotechnol Sci Appl 3:23-28
67. Lee P, Zhang R, Li V et al (2012) Enhancement of anticancer efficacy using modified lipophilic nanoparticle drug encapsulation. Int J Nanomedicine 7:731-737
68. Klutz K, Russ V, Willhauck MJ et al (2009) Targeted radioiodine therapy of neuroblastoma tumors following systemic nonviral delivery of the sodium iodide symporter gene. Clin Cancer Res 15:6079-6086
69. Zoubek A, Emminger W, Emminger-Schmidmeier W, Peters C, Pracher E, Grois N, Gadner H (1992) Conventional vs. liposomal amphotericin B in immunosuppressed children. Pediatr Hematol Oncol 9(2):187-190
70. Cowens JW, Creaven PJ, Greco WR, Brenner DE, Tung Y, Ostro M, Pilkiewicz F, Ginsberg R, Petrelli N (1993) Initial clinical (phase I) trial of TLC D-99 (doxorubicin encapsulated in liposomes). Cancer Res 53(12):2796-2802
71. Presant CA, Scolaro M, Kennedy P, Blayney DW, Flanagan B, Lisak J, Presant J (1993) Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma. Lancet 341(8855): 1242-1243
72. Barreiro E, Casas JS, Couce MD et al (2007) Synthesis and antimicrobial activities of silver(I) sulfanylcarboxylates. Structural isomers with identically or unequally coordinated Ag centers in an Ag4S4 ring. Dalton Trans 28:3074-3085
73. Thomas V, Yallapu MM, Sreedhar B et al (2007) A versatile strategy to fabricate hydrogel-silver nanocomposites and investigation of their antimicrobial activity. J Colloid Interface Sci 315:389-395
74. Gravante G, Caruso R, Sorge R et al (2009) Nanocrystalline silver: a systematic review of randomized trials conducted on burned patients and an evidence-based assessment of potential advantages over older silver formulations. Ann Plast Surg 63:201-205
75. Tian J, Wong KK, Ho CM et al (2007) Topical delivery of silver nanoparticles promotes wound healing. Chem Med Chem 2: 129-136
76. Wong KK, Cheung SO, Huang L et al (2009) Further evidence of the anti-inflammatory effects of silver nanoparticles. Chem- MedChem 4:1129-1135
77. Yin HQ, Langford R, Burrell RE (1999) Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing. J Burn Care Rehabil 20:195-200
78. Huang Y, Li X, Liao Z, Zhang G, Liu Q, Tang J, Peng Y, Liu X, Luo Q (2007) A randomized comparative trial between Acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis. Burns 33(2):161-166
79. Cox SG, Cullingworth L, Rode H (2011) Treatment of paediatric burns with a nanocrystalline silver dressing compared with standard wound care in a burns unit: a cost analysis. S Afr Med J 101(10):728-731
80. Silver GM, Robertson SW, Halerz MM, Conrad P, Supple KG, Gamelli RL (2007) A silver-coated antimicrobial barrier dressing used postoperatively on meshed autografts: a dressing comparison study. J Burn Care Res 28(5):715-719
81. Khare MD, Bukhari SS, Swann A et al (2007) Reduction of catheter-related colonisation by the use of a silver zeoliteimpregnated central vascular catheter in adult critical care. J Infect 54:146-150
82. Cohen MS, Stern JM, Vanni AJ et al (2007) In vitro analysis of a nanocrystalline silver-coated surgical mesh. Surg Infect (Larchmt) 8:397-403
83. Annemans L, Lencioni R, Warie H, Bartolozzi C, Ciceri M, Müller U (2008) Health economic evaluation of ferucarbotranenhanced MRI in the diagnosis of liver metastases in colorectal cancer patients. Int J Colorectal Dis 23(1):77-83
84. Lu M, Cohen MH, Rieves D, Pazdur R (2010) FDA report: ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease. Am J Hematol 85(5):315-319
85. Veiseh O, Kievit FM, Fang C et al (2010) Chlorotoxin bound magnetic nanovector tailored for cancer cell targeting, imaging, and siRNA delivery. Cancer Res 70:7553-7561
86. Kumar M, Yigit M, Dai G et al (2010) Image-guided breast tumor therapy using a small interfering RNA nanodrug. Cancer Res 70:7553-7561
87. Hua MY, Yang HW, Chuang CK et al (2010) Magnetic-nanoparticle- modified paclitaxel for targeted therapy for prostate cancer. Biomaterials 31:7355-7363
88. Kievit FM, Wang FY, Fang C et al (2011) Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro. J Control Release 152:76-83
89. Hadjipanayis CG, Machaidze R, Kaluzova M et al (2010) EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma. Cancer Res 70: 6303-6312
90. Santra S, Kaittanis C, Perez JM (2010) Cytochrome C encapsulating theranostic nanoparticles: a novel bifunctional system for targeted delivery of therapeutic membrane-impermeable proteins to tumors and imaging of cancer therapy. Mol Pharm 7:1209-1222
91. Mahapatro A, Singh DK (2011) Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J Nanobiotechnology 9:55
92. Takács AI, Kovács I, Miháltz K, Filkorn T, Knorz MC, Nagy ZZ (2012) Central corneal volume and endothelial cell count following femtosecond laser-assisted refractive cataract surgery compared to conventional phacoemulsification. J Refract Surg 28(6):387-392
93. Di DR, He ZZ, Sun ZQ, Liu J (2012). A new nano-cryosurgical modality for tumor treatment using biodegradable MgO nanoparticles. Nanomedicine (epub ahead of print)
94. Liu X, Lee PY, Ho CM et al (2010) Silver nanoparticles mediate differential responses in keratinocytes and fibroblasts during skin wound healing. Chem Med Chem 5:468-475
95. Kwan KH, Liu X, To MK et al (2011) Modulation of collagen alignment by silver nanoparticles results in better mechanical properties in wound healing. Nanomedicine 7:497-504
96. Polini A, Pisignano D, Parodi M, Quarto R, Scaglione S (2011) Osteoinduction of human mesenchymal stem cells by bioactive composite scaffolds without supplemental osteogenic growth factors. PLoS One 6(10):e26211
97. Rodrigues MT, Martins A, Dias IR, Viegas CA, Neves NM, Gomes ME, Reis RL (2012) Synergistic effect of scaffold composition and dynamic culturing environment in multilayered systems for bone tissue engineering. J Tissue Eng Regen Med (epub ahead of print)
98. 2 composite scaffold for bone tissue engineering. J Biomed Nanotechnol 8(1):149-160
99. Hu NM, Chen Z, Liu X, Liu H, Lian X, Wang X, Cui FZ (2012) Mechanical properties and in vitro bioactivity of injectable and self-setting calcium sulfate/nano-HA/collagen bone graft substitute. J Mech Behav Biomed Mater 12C:119-128
100. Wu C, Miron R, Sculean A et al (2011) Proliferation, differentiation and gene expression of osteoblasts in boron-containing associated with dexamethasone deliver from mesoporous bioactive glass scaffolds. Biomaterials 32:7068-7078
101. Zanello LP, Zhao B, Hu H et al (2006) Bone cell proliferation on carbon nanotubes. Nano Lett 6:562-567
102. Sahoo S, Ang LT, Goh JC, Toh SL (2010) Growth factor delivery through electrospun nanofibers in scaffolds for tissue engineering applications. J Biomed Mater Res A 93:1539-1550
103. Mima Y, Fukumoto S, Koyama H, Okada M, Tanaka S, Shoji T, Emoto M, Furuzono T, Nishizawa Y, Inaba M (2012) Enhancement of cell-based therapeutic angiogenesis using a novel type of injectable scaffolds of hydroxyapatite- polymer nanocomposite microspheres. PLoS One 7(4):e35199
104. Liu T, Xu J, Chan BP, Chew SY (2012) Sustained release of neurotrophin-3 and chondroitinase ABC from electrospun collagen nanofiber scaffold for spinal cord injury repair. J Biomed Mater Res A 100:236-242
105. Ellis-Behnke RG, Liang YX, You SW et al (2006) Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. Proc Natl Acad Sci USA 103:5054-5059
106. Segers VF, Tokunou T, Higgins LJ, MacGillivray C, Gannon J, Lee RT (2007) Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation 116:1683-1692